ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013
Follow Pharmacy_Times:
PRESS RELEASE

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
 
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
 
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
 
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Related Articles
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses measures of gauging stroke.
Ashley Huntsberry and Joselyn Benabe from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences competed against a record number of participants to win the 19th annual ASHP National Clinical Skills Competition SM, held December 7, 2014, during the ASHP Midyear Clinical Meeting in Anaheim, CA.
Binita Patel, PharmD, MS, explains the role telehealth and telepharmacy will play in patient management.
Binita Patel, PharmD, MS, discusses how provider status would affect reimbursement models in ambulatory pharmacy.
Latest Issues
$auto_registration$